Theranostics 2018; 8(18):4985-4994. doi:10.7150/thno.27728

Research Paper

Early prediction of revascularisation by angiomotin-targeting positron emission tomography

Anais Moyon1,2,3✉, Philippe Garrigue1,2,3, Laure Balasse2, Samantha Fernandez2, Pauline Brige2, Marie Nollet1, Guillaume Hache1,2, Marcel Blot-Chabaud1, Françoise Dignat-George1,4, Benjamin Guillet1,2,3 ✉

1. Aix Marseille Univ, INSERM 1263, INRA 1260, C2VN, Marseille, France.
2. Aix-Marseille Univ, CERIMED, Marseille, France.
3. Service de Radiopharmacie, APHM, Marseille, France.
4. Service d'Hématologie, Hôpital Conception, APHM, Marseille, France.

Abstract

This study aimed to develop a PET imaging agent of angiomotin (AMOT) expression, a potential biomarker of functional tissue regeneration in post-ischaemic conditions.

Methods: Hindlimb ischaemia was induced by ligature and resection of the right femoral artery in mice, and clinical score and limb perfusion were evaluated up to 30 days after surgery. AMOT expression was evaluated by histology and Western blot analysis. NODAGA-conjugates of AMOT ligand, sCD146, were designed, synthesised and radiolabelled with gallium-68. 68Ga-sCD146 microPET/CT imaging was performed from day 1 to day 30 after ischaemia. 68Ga-sCD146 specificity for AMOT was evaluated by autoradiography.

Results: Immunohistochemistry showed a significant endothelial overexpression of AMOT from day 5 up to day 10 in the ischaemic hindlimb. 68Ga-sCD146 PET signal intensity correlated significantly with AMOT immunohistochemistry evaluation. 68Ga-sCD146 PET imaging showed a significant uptake in the ischaemic hindlimb from day 2 to day 15, peaking on day 5 (ipsi/contralateral ratio = 2.4 ± 1.3, P = 0.0005) and significantly decreased after pharmacological blocking (62.57 ± 11% decrease in PET signal P = 0.032). Finally, we observed a significant correlation between day 5 68Ga-sCD146 PET signal intensity and clinical recovery (day 28) or hindlimb perfusion recovery (day 30).

Conclusions: This work reports for the first time an early and sustained increase in AMOT expression after hindlimb ischaemia in mice. We therefore developed an AMOT-targeting imaging agent, 68Ga-sCD146, and showed its specific uptake up to 21 days after ischaemic hindlimb using microPET imaging. Correlation of early post-ischaemic PET signal with both delayed perfusion recovery and clinical outcome allows us to postulate that 68Ga-sCD146 represents a promising radiotracer for tissue angiogenesis assessment.

Keywords: angiomotin, ischaemia, sCD146, Gallium, angiogenesis.

This is an open access article distributed under the terms of the Creative Commons Attribution (CC BY-NC) license (https://creativecommons.org/licenses/by-nc/4.0/). See http://ivyspring.com/terms for full terms and conditions.
How to cite this article:
Moyon A, Garrigue P, Balasse L, Fernandez S, Brige P, Nollet M, Hache G, Blot-Chabaud M, Dignat-George F, Guillet B. Early prediction of revascularisation by angiomotin-targeting positron emission tomography. Theranostics 2018; 8(18):4985-4994. doi:10.7150/thno.27728. Available from http://www.thno.org/v08p4985.htm